Based on pathophysiological mechanisms and limited pre-clinical and clinical data , adjunctive immune-stimulatory therapy with interferon-gamma ( IFN - ) may represent a promising candidate to improve outcome of invasive fungal infections by enhancing host defence mechanisms .